COVID and Diabetes Combined Are Clear and Present Dangers - Here is What we Can Do to Reduce Risk.

Monoclonal antibodies were first used in humans in the 1980s². They have gradually become more prevalent with Regeneron, producing and selling this treatment for those with severe COVID-19

Ivermectin has shown promise as a potential treatment. It needs to be urgently evaluated under the guidance of the FDA

Health system CFOs across the country face a unique quandary. Operating margins remain low, staffing shortages restrict services, and industry-wide buying power is waning.